about
Subcutaneous or intramuscular methotrexate for rheumatoid arthritisErythropoiesis-stimulating agents for anemia in rheumatoid arthritisInterventions for periodontal disease in people with rheumatoid arthritisOfatumumab for rheumatoid arthritisTocilizumab for rheumatoid arthritisNon-biologic pharmaceutical interventions for fatigue in rheumatoid arthritisAdverse effects of biologics: a network meta-analysis and Cochrane overviewTocilizumab for rheumatoid arthritisGolimumab for rheumatoid arthritisBiologic interventions for fatigue in rheumatoid arthritisPlatelets amplify inflammation in arthritis via collagen-dependent microparticle productionBiologic interventions for fatigue in rheumatoid arthritisIL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceEfficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project.Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.Smoking and outcomes after knee and hip arthroplasty: a systematic reviewEfficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study.Cytokine-mediated bone destruction in rheumatoid arthritis.Interleukin-1 receptor blockade in perinatal brain injury.Advances in the medical treatment of rheumatoid arthritis.Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reportsThe role of IL-1β in the bone loss during rheumatic diseases.Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.Update on islet transplantation.cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-SeqCalcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretionTransient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling.Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.IL-1 drives breast cancer growth and bone metastasis in vivo.The discovery of novel experimental therapies for inflammatory arthritis.The effect of inflammatory cytokines in alcoholic liver disease.New treatments for inflammatory rheumatic disease.Protective and detrimental roles of inflammasomes in disease.Role of biologics in intractable urticaria.Combination Immunotherapy for Type 1 Diabetes.Fungal Infections and New Biologic Therapies.Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects.
P2860
Q24187565-CD6B0289-8CED-48E5-B25E-89BEE49B4075Q24200775-5553C8AD-8371-493A-A28C-4C47320618D2Q24200961-2FA2128E-9531-4EE3-A01A-F531AFB051BBQ24202719-C5B0FE8B-6E6E-4BD4-BD29-27DEE5B94037Q24234126-9571F9D4-E1AF-4EDB-82C7-0AD2D0D37216Q24234928-B74AE1EB-FBDB-4B92-8613-ABFDE89CFEFDQ24235218-179F70AF-35B5-4FBC-B8FE-3978A2077E80Q24239949-8E9097C9-BA9E-49C4-9026-62037BABF49CQ24240895-B46F02B1-E62B-49DD-B713-42538E87C978Q24241246-AA807169-87E3-4B8B-9BC7-C0EE0F04530EQ24627618-ADC8E37B-0432-42F8-930B-A251619E18CFQ26471538-CEE6D500-765A-41B8-8948-848BF3AC8727Q27008536-BFC7EA02-EE54-4D9B-92EE-A8869690E147Q33573112-C5925581-21E6-4CBB-A21E-C8CB2F4CFF85Q33684200-83A0C054-C4EA-4B1C-A6F5-8A280C51C36BQ33776622-39D4AA44-BAC7-4D2E-BD64-5FE67198515DQ33953931-EBF8277F-7020-457D-8951-043BE7F1697BQ34252489-1A435A90-1E42-49E9-BC6F-68426EE0CFACQ34297349-F358056B-97EA-40BF-8EBC-79A09BC474F6Q35102474-9FDC41F0-724B-41C2-9AA7-47D16D219C0FQ35225125-6CA746E5-1EC0-40C2-A05D-BD1084508140Q35540844-E53328E0-F024-4FDF-82BB-0148AF0FE9F5Q35683994-82360E6C-707C-4D92-9C31-7AD63E4B81CDQ36065843-49263209-7D41-4071-BF5A-EC680094D68FQ36098311-0C46CC8A-D4FE-4D4A-9053-1B425BB78513Q36195284-8D9B0CE1-913E-4D30-8823-B79A0890B6DFQ36243217-B5F5066F-7C0F-471A-84B7-4D2141191AAAQ36497205-2C538255-9A70-42B1-AD26-C9C0ECCC628FQ36606116-4ACD15EA-FE0F-406C-829E-F1DB3C50314AQ37118963-27E0E100-1660-4E4E-BA6A-33FFED8A7C73Q37428436-D3271C96-A0FE-427C-A115-C948F30F8588Q37688987-BD94E061-C209-456F-8A1C-36620156AEB7Q37719255-7068610E-5295-45D6-B55C-E32AC1D24ED5Q38175384-A96CEC27-53C0-444D-8ECE-1D2E55CDACFAQ38266252-CCAF037B-42E9-4B48-BB32-092016367567Q38431249-FEDA0D18-8E10-436C-94CA-7732932B4A06Q38450662-D39BEA06-47C6-432A-B795-54D039F539B0Q38680333-C27956D7-CF2F-44D0-8C36-EF9CFE5F32FBQ38794862-68D9F52F-4562-40F0-BA22-3E6BD22542D4Q38799905-FAFEE773-4F53-4984-8B21-C49C0790C92A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anakinra for rheumatoid arthritis
@ast
Anakinra for rheumatoid arthritis
@en
Anakinra for rheumatoid arthritis
@en-gb
Anakinra for rheumatoid arthritis
@nl
type
label
Anakinra for rheumatoid arthritis
@ast
Anakinra for rheumatoid arthritis
@en
Anakinra for rheumatoid arthritis
@en-gb
Anakinra for rheumatoid arthritis
@nl
prefLabel
Anakinra for rheumatoid arthritis
@ast
Anakinra for rheumatoid arthritis
@en
Anakinra for rheumatoid arthritis
@en-gb
Anakinra for rheumatoid arthritis
@nl
P2860
P3181
P1476
Anakinra for rheumatoid arthritis
@en
P2093
Marty Mertens
P2860
P3181
P356
10.1002/14651858.CD005121.PUB3
P577
2009-01-21T00:00:00Z